SCHEMBL2033642

SCHEMBL2033642

CCCCCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11305 1.00
SCHEMBL169459 0.96
SCHEMBL11100623 0.96 TSHR (0.61)
SCHEMBL5571338 0.96 TSHR (0.61)
SCHEMBL20610044 0.96 TSHR (0.61)
SCHEMBL307959 0.96 TSHR (0.61)
SCHEMBL5574655 0.96 TSHR (0.61)
SCHEMBL9023160 0.96 TSHR (0.61)
SCHEMBL5273324 0.96 TSHR (0.61)
SCHEMBL22186740 0.96 TSHR (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108586353-A A kind of luminous organic material and its preparation method and application based on anthracene and its derivative 华南理工大学 2018-09-28 CN claimed
US-4638082-A Method of producing the p-chlorophenol ester of p-chlorophenoxyisobutyric acid SOCIETE CORIAL, S.A. (FR) 1987-01-20 US claimed
WO-2024137752-A1 AZEPINO[4,5-B]INDOLONE CGAS INHIBITORS ELI LILLY AND COMPANY (US) 2024-06-27 WO disclosed
CN-116239623-A Preparation method and application of boric acid ester 江西亚太科技发展有限公司 2023-06-09 CN disclosed
WO-2023031972-A1 NOVEL SOLID STATE EMITTERS BASED ON PYRIDINIUM SCAFFOLDS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2023-03-09 WO disclosed
EP-3915557-A1 METHODS OF USE FOR TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS Aurigene Discovery Technologies Limited (IN) 2021-12-01 EP disclosed
US-11147801-B2 Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2021-10-19 US disclosed
EP-3615027-B1 METHODS OF USE FOR TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS AURIGENE DISCOVERY TECH LTD (IN) 2021-07-14 EP disclosed
CN-112789035-A Benzocycloheptene analogs and related compounds having activity as anticancer agents 贝勒大学 2021-05-11 CN disclosed
CN-110997654-A Indole derivatives and uses thereof 诺华股份有限公司 2020-04-10 CN disclosed
US-20200078339-A1 METHODS OF USE FOR TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS AURIGENE ONCOLOGY LIMITED (IN) 2020-03-12 US disclosed
US-20070060584-A1 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers MERCK & CO., INC. 2007-03-15 US disclosed
US-20060183785-A1 Biaryl substituted pyrazoles as sodium channel blockers MERCK SHARP & DOHME CORP. 2006-08-17 US disclosed
EP-1622911-A2 PYRROLO[1,2-B]PYRIDAZINE COMPOUNDS AND THEIR USE AS CRF-1 RECEPTOR ANTAGONISTS Pharmacia & Upjohn Company LLC (US) 2006-02-08 EP disclosed
EP-1618099-A2 BIARYL SUBSTITUTED THIAZOLES, OXAZOLES AND IMIDAZOLES AS SODIUM CHANNEL BLOCKERS Merck & Co., Inc. (US) 2006-01-25 EP disclosed
EP-1615895-A1 BIARYL SUBSTITUTED PYRAZOLES AS SODIUM CHANNEL BLOCKERS Merck & Co., Inc. (US) 2006-01-18 EP disclosed
US-20040242587-A1 Pyrrolo[1,2-b]pyridazine compounds PFIZER INC 2004-12-02 US disclosed
WO-2004099213-A2 PYRROLO (1,2-B) PYRIDAZINE COMPOUNDS AND THEIR USE AS CRF-1 RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-11-18 WO disclosed
WO-2004094395-A2 BIARYL SUBSTITUTED THIAZOLES, OXAZOLES AND IMIDAZOLES AS SODIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2004-11-04 WO disclosed
WO-2004092140-A1 BIARYL SUBSTITUTED PYRAZOLES AS SODIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2004-10-28 WO disclosed